Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009
Author(s) -
Melissa McCracken,
Alice Wong,
Richard Mitchell,
Denise Gravel,
John Conly,
John M. Embil,
Lynn Johnston,
Anne Matlow,
Debbie Ormiston,
Andrew E. Simor,
Stephanie Smith,
Tim Du,
Romeo Hizon,
M. R. Mulvey
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt054
Subject(s) - epidemiology , vancomycin resistant enterococci , epidemiological surveillance , bacteremia , medicine , molecular epidemiology , enterococcus , vancomycin resistant enterococcus , vancomycin , intensive care medicine , microbiology and biotechnology , antibiotics , biology , staphylococcus aureus , bacteria , biochemistry , genotype , gene , genetics
Vancomycin-resistant enterococci (VRE) can be associated with serious bacteraemia. The focus of this study was to characterize the molecular epidemiology of VRE from bacteraemia cases that were isolated from 1999 to 2009 as part of Canadian Nosocomial Infection Surveillance Program (CNISP) surveillance activities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom